BPC 2mg + TB 2mg

BPC 2mg + TB 2mg from the Nexus Healing & Recovery catalog, supplied for controlled in-vitro research workflows.
Ships from the US with tracking.
Catalog active: Catalog pricing is active. Live warehouse counts are not published.
Certificate pending — assay values withheld
Final assay values publish here once independent documentation is available. See the verification process.
For in-vitro research use only. Not for human consumption.
This blend combines two of the most studied tissue-research peptides. BPC-157 acts through nitric oxide and growth factor pathways (VEGF, EGF, FAK-paxillin), while TB-500 works through actin polymerization and cell migration mechanisms. Researchers investigate whether their complementary mechanisms produce additive or synergistic effects in tissue remodeling models.
No sequence is listed in the current catalog record for this product.
- CAS
- N/A
- MW
- BPC-157: 1419.53 g/mol + TB-500: 4963.50 g/mol
- Sequence
- Not listed
- Half-life
- Not listed
- Formula
- Not listed
- Purity
- Certificate pending
- Form
- Lyophilized powder
- Class
- Research Peptide Blend
The dossier.
Compound Overview
This two-component research blend places BPC-157 and TB-500 into a single lyophilized vial format. BPC-157 is investigated through nitric oxide and growth factor pathways (VEGF, EGF, FAK-paxillin), while TB-500 is studied through actin polymerization and cell migration mechanisms. In laboratory tissue remodeling models, researchers evaluate whether those complementary mechanisms demonstrate additive or synergistic behavior under controlled experimental conditions.
Research Background & Published Literature
BPC-157 and TB-500 have been studied separately across more than 100 published papers combined. The blended format gives laboratories one setup for examining possible interactions between gastric cytoprotection pathways associated with BPC-157 and actin-mediated tissue repair pathways associated with TB-500.
Researchers reviewing the literature around this compound can use the peer-reviewed resources below for additional context on mechanism of action, signaling pathways, and controlled laboratory research applications:
- Vasireddi et al. (2025) — HSS J
- McGuire et al. (2025) — Curr Rev Musculoskelet Med
- Bock-Marquette et al. (2023) — Int Immunopharmacol
- Nguyen et al. (2025) — Invest Ophthalmol Vis Sci
Storage, Handling & Stability Guidelines
Use the applicable lot/source record for storage of unopened material. Any diluent selection, preparation, temperature, aliquoting, or post-reconstitution hold conditions must be established by a qualified laboratory under a validated SOP; this page does not establish a stability window.
- Keep ambient-temperature handling time as short as practical to support compound integrity.
- Reseal vials promptly after each withdrawal to reduce moisture exposure.
- Use appropriate personal protective equipment and follow institutional chemical safety protocols at all times.
- For traceability, label all aliquots with compound name, concentration, reconstitution date, and operator initials.
Quality Assurance & Lab Verification
The Certificate of Analysis for this catalog item is pending. No provisional batch, assay, method, analyst, or release data is published in this product dossier. Check the Lab Verified archive for documentation status.
Shipping
Orders ship within the United States via USPS; international orders are not accepted. Laboratories should follow their validated SOP together with any handling fields published for the represented product or lot; no universal prepared-solution condition is inferred here.
Compound details.
- Molecular Weight
- BPC-157: 1419.53 g/mol + TB-500: 4963.50 g/mol
- Class
- Research Peptide Blend
Research context.
Both peptides have been studied individually in over 100 published papers combined. The blended format allows researchers to study potential synergistic interactions between gastric cytoprotection pathways (BPC-157) and actin-mediated tissue repair pathways (TB-500) in a single experimental setup.
Verification standard.
Certificate information is lot-specific. A finalized public record shows only the methods, fields, and results present for that named lot. A pending certificate state exposes no assay values and must not be interpreted as analytical verification. Review Nexus lab verification.
Certificate status.
Finalized independent certificate documentation is pending for this catalog record. Measurement details remain withheld until the certificate is available.
- Sequence
- Not listed
- Model preview
- Unavailable
Molecular model preview is unavailable for this catalog record.
The chemistry.
Combination of 15-amino acid gastric peptide (BPC-157) and 43-amino acid thymosin fragment (TB-500)
Technical specifications.
- Product Name: BPC-157 + TB500 Blend
- Classification: Research Peptide Blend
- Structural Description: Combination of 15-amino acid gastric peptide (BPC-157) and 43-amino acid thymosin fragment (TB-500)
- Molecular Weight: BPC-157: 1419.53 g/mol + TB-500: 4963.50 g/mol
- Purity: ≥99% (verified by HPLC and Mass Spectrometry)
- Physical Form: Lyophilized (freeze-dried) powder
- Intended Use: In-vitro research use only — not for human consumption
Related research compounds
Comparable catalog records with published variants and certificate status.
- Healing & RecoveryVerified batchBPC 157PriceFrom $30.99Formats4 sizes
Compare size options, price, and certificate status before opening the product record.
CAS 137525-51-0View product - Healing & RecoveryVerified batchTB500 (Thymosin B4 Acetate)PriceFrom $30.99Formats4 sizes
Compare size options, price, and certificate status before opening the product record.
CAS 77591-33-4View product - Healing & RecoveryCertificate pendingTB500 (FRAG)Price$60.99Formats1 size
Compare size options, price, and certificate status before opening the product record.
View product - Healing & RecoveryVerified batchBPC 5mg + TB 5mgPrice$80.99Formats1 size
Compare size options, price, and certificate status before opening the product record.
View product - Healing & RecoveryCertificate pendingBPC 10mg + TB 10mgPrice$132.99Formats1 size
Compare size options, price, and certificate status before opening the product record.
View product
BPC 2mg + TB 2mg research FAQ.
What is BPC 2mg + TB 2mg used for in research?
BPC 2mg + TB 2mg is supplied for controlled in-vitro research workflows in the Healing & Recovery category. It is not labeled for human or veterinary use.
Does BPC 2mg + TB 2mg have a finalized analytical record?
BPC 2mg + TB 2mg is listed with certificate-pending status until a finalized lot-specific COA record is available.
Which BPC 2mg + TB 2mg variants are published?
Published Nexus variants include 4mg.
Does BPC 2mg + TB 2mg include a COA?
The current Nexus record marks BPC 2mg + TB 2mg as certificate pending; finalized assay values are not shown until lot-specific documentation is available.